Medicare Enrolled
Dr. Haotong Wang, M.D.
Student in an Organized Health Care Education/Training Program · Cedar Park, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wang
Dr. Haotong Wang is a student in an organized health care education/training program specialist in Cedar Park, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 33,599 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wang received a total of $4,202 from 53 pharmaceutical and/or device companies across 187 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years of NPI registration
▲ Top 1% volume in TX
$4,202 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗33,599
Medicare services
Top 1% in TX for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
13,050 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 12,100 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
3,900 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
834 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
629 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
557 | $8 | $36 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
475 | $130 | $496 |
| Anti-nausea injection (Aloxi/palonosetron) | 430 | $1 | $114 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
199 | $87 | $368 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
163 | $98 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
162 | $22 | $157 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
90 | $45 | $313 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
76 | $17 | $60 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
75 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
75 | $6 | $34 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
73 | $5 | $431 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
60 | $2 | $19 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
48 | $11 | $108 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
46 | $21 | $161 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
45 | $1 | $7 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
38 | $14 | $100 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 37 | $20 | $128 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
36 | $10 | $75 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
35 | $15 | $76 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
34 | $14 | $73 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $111 | $565 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
34 | $1 | $8 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $24 | $256 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $10 | $96 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
30 | $49 | $344 |
| New patient office visit, complex (60-74 min) | 26 | $168 | $709 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
24 | $11 | $99 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
24 | $16 | $80 |
| Immunologic analysis of serum A laboratory test that uses immunologic techniques to analyze components in a blood serum sample. |
24 | $29 | $108 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
24 | $22 | $160 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
24 | $60 | $264 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $133 | $694 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
11 | $5 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.7% high complexity
90.9% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,202
Total received (2019-2024)
Avg $840/year across 5 years
Top 9% in TX for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
187
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,911
2023
$1,564
2022
$374
2020
$280
2019
$73
Payments by company (2024)
PFIZER INC.
$178
Janssen Biotech, Inc.
$158
Sirtex Medical Inc
$120
Takeda Pharmaceuticals U.S.A., Inc.
$106
Astellas Pharma US Inc
$106
Novartis Pharmaceuticals Corporation
$100
E.R. Squibb & Sons, L.L.C.
$94
Merck Sharp & Dohme LLC
$94
AstraZeneca Pharmaceuticals LP
$80
ABBVIE INC.
$66
Incyte Corporation
$47
Genmab U.S., Inc.
$45
ARRAY BIOPHARMA INC
$45
Celgene Corporation
$44
Secura Bio, Inc.
$44
TAIHO ONCOLOGY, INC.
$42
Regeneron Healthcare Solutions, Inc.
$42
GENZYME CORPORATION
$39
JAZZ PHARMACEUTICALS INC.
$38
Kite Pharma, Inc.
$32
Adaptive Biotechnologies Corporation
$29
Stemline Therapeutics Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$28
BeiGene USA, Inc.
$26
Pharmacosmos Therapeutics Inc.
$24
SOBI, INC
$23
EMD Serono, Inc.
$22
ADC Therapeutics America, Inc.
$22
Eisai Inc.
$22
Aveo Pharmaceuticals, Inc.
$22
PUMA BIOTECHNOLOGY, INC.
$20
GlaxoSmithKline, LLC.
$19
Ipsen Biopharmaceuticals, Inc
$19
Mirati Therapeutics, Inc.
$18
Blueprint Medicines Corporation
$18
Rigel Pharmaceuticals, Inc.
$18
Karyopharm Therapeutics Inc.
$18
Acrotech Biopharma Inc.
$15
Top 3 companies account for 23.9% of 2024 payments
All-time payments by company (2019-2024) ›
PFIZER INC.
$313
Novartis Pharmaceuticals Corporation
$253
Incyte Corporation
$252
Janssen Biotech, Inc.
$215
Astellas Pharma US Inc
$197
Merck Sharp & Dohme LLC
$171
Rigel Pharmaceuticals, Inc.
$168
E.R. Squibb & Sons, L.L.C.
$164
AstraZeneca Pharmaceuticals LP
$162
Celgene Corporation
$151
Takeda Pharmaceuticals U.S.A., Inc.
$138
Amgen Inc.
$130
Seagen Inc.
$124
Sirtex Medical Inc
$120
GENZYME CORPORATION
$112
EMD Serono, Inc.
$84
Regeneron Healthcare Solutions, Inc.
$84
Mirati Therapeutics, Inc.
$76
GlaxoSmithKline, LLC.
$71
ABBVIE INC.
$66
ARRAY BIOPHARMA INC
$66
MorphoSys, US Inc.
$61
TAIHO ONCOLOGY, INC.
$60
Genmab U.S., Inc.
$60
Karyopharm Therapeutics Inc.
$50
Kite Pharma, Inc.
$49
Pharmacyclics LLC, An AbbVie Company
$49
Adaptive Biotechnologies Corporation
$45
SOBI, INC
$45
Secura Bio, Inc.
$44
Lilly USA, LLC
$43
ADC Therapeutics America, Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$40
JAZZ PHARMACEUTICALS INC.
$38
Apellis Pharmaceuticals, Inc.
$37
Ipsen Biopharmaceuticals, Inc
$37
Deciphera Pharmaceuticals Inc.
$30
Foundation Medicine, Inc.
$29
Stemline Therapeutics Inc.
$28
Bayer Healthcare Pharmaceuticals Inc.
$28
BeiGene USA, Inc.
$26
Tactile Systems Technology Inc
$26
Alexion Pharmaceuticals, Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
AVEO Pharmaceuticals, Inc.
$23
Eisai Inc.
$22
Aveo Pharmaceuticals, Inc.
$22
Genentech USA, Inc.
$22
Blueprint Medicines Corporation
$18
EISAI INC.
$16
Exelixis Inc.
$16
Acrotech Biopharma Inc.
$15
Puma Biotechnology, Inc.
$14
Top 3 companies account for 19.5% of all-time payments
Associated products mentioned in payments ›
ALIMTA · AUGTYRO · AYVAKIT · BAVENCIO · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · COPIKTRA · CRESEMBA · DARZALEX · DOPTELET · Doptelet · ELZONRIS · ENJAYMO · EPKINLY · ERLEADA · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · Flexitouch Plus · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · OJJAARA · OPDIVO · OPDUALAG · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TAFINLAR · TECVAYLI · TEPMETKO · TUKYSA · Tavalisse · ULTOMIRIS · VENCLEXTA · VERZENIO · VPRIV · Venclexta · Vyloy · XALKORI · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
790
County median income
$108,309
Nearest hospital to ZIP centroid (approximate)
CEDAR PARK REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wang is a mixed practice specialist, with above-average Medicare volume (top 1% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wang experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Wang performed 13,050 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $4,202 from 53 companies across 187 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other student in an organized health care education/training programs in Cedar Park?
Dr. Wang's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Cedar Park
Browse student in an organized health care education/training programs in Cedar Park ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in TX
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in TX
Which TX student in an organized health care education/training programs receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology